High-throughput screening: Advances in assay technologies

Journal of Clinical Ligand Assay

Volumn 21, Issue 2, 1998, Pages 239-246

  Sitta Sittampalam, G ^a,b   Kahl, Steven D ^a,b   Janzen, William P ^a,b  

^a ELI LILLY AND COMPANY   (United States)

^b Sphinx Pharmaceuticals Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0004558052     PISSN: 10811672     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (72)

1. Oliver SG: From DNA sequence to biological function. Nature 1996;379:597-600.
2. Baum R: Combinatorial chemistry. C/iem Eng News; February 12, 1996:28-54.
3. 3.Broach JR, Thorner J: High throughput screening for drug discovery. Nature 1996;384:14-16.
4. 4.' Janzen WP: High throughput screening as a discovery tool in the pharmaceutical industry. Lab Robotics Automation 1996;8:261265.
5. An industrial perspective on steps leading up to the implementation of high-throughput screening is given in this paper. Topics covered include organizational interactions, the screening paradigm employed, and how assays are converted to screens.
6. Fernandes PB: Letter from the society president. J Biomol Screening 1997;2:1.
7. 6.Burbaum JJ, Sigal NH: New technologies for high-throughput screening. Curr Opin Chem Biol 1997; 1:72-78. An excellent review of new technologies for high-throughput screening. The paper contains references on nonradioactive assay technologies, screening methods for combinatorial libraries, and issues associated with assay miniaturization.
8. l: Sittampalam GS, Iversen PW, Boadt JA, Kahl SD, Bright S, Zock JM, Janzen WP, Lister MD: Design of signal windows in high throughput screening assays for drug discovery. J Biomol Screening 1997;2:159-169. This paper describes the concept of signal windows, which provides a degree of separation between measured signals. The size of the signal window is a critical performance parameter (in high-throughput screens) which impacts the identification of active compounds (hits) in the presence of varibility.
9. Hook D: Ultra high throughput screening-a journey into Nanoland with Gulliver and Alice. Drug Discov Tech 1996; 1:267-268.
10. Braunwalder AF, Wennogle L, Gay B, Lipson KE, Sills MA: Application of scintillation microtiter plates to measure phosphopeptide interactions with GRB2-SH2 binding domain. J Biomol Screening 1996; 1:23-26.
11. Cole JL: Approaches to high volume screening assays of viral polymerases and related proteins. Methods Enzymol 1996;275:310328.
12. 11.' Cook ND: Scintillation proximity assay: a versatile high throughput screening technology. Drug Discov Tech 1996,1:287-294. A good account of the basic principles of the scintillation proximity assay and its specific applications in high-throughput screening, with 70 references cited.
13. 12.' Kahl SD, Hubbard FR, Sittampalam GS, Zock JM: Validation of a high throughput scintillation proximity assay for 5hydroxytryptamine1E receptor binding activity. J Biomol Screening 1997;2:33-40.
14. This paper describes the development of a scintillation proximity assay for receptor binding studies in high-throughput mode. Validation concepts and factors affecting robustness of the assays in highthroughput screening mode are addressed in detail.
15. Lerner CG, Chiang Saiki AY, Mackinnon CA, Xuei X: High throughput screen for inhibitors of bacterial DNA topoisomerase 1 using scintillation proximity assay. J Biomol Screening 1996; 1:135143.
16. BakerCA,PoormanRA,KezdyFJ,StaplesDJ,SmithCW,Elhammer AP: A scintillation proximity assay for UDP-GaINAc:polypeptide, NAcetylgalactosaminyltransferase. Anal Biochem 1996;239:20-24.
17. 15.' Buam EZ, Johnston SH, Berbernitz GA, Gluzman Y: Development of scintillation proximity assay for human cytomegalovirus protease using -phosphorus. Anal Biochem 1996; 237:129-134. This paper demonstrates the use of 33P as a label in a scintillation proximity assay system. The authors demonstrate the utility of a simple mix and measure assay to screen for protease inhibitors.
18. Sullivan E, Hemsley P, Pickard A: Development of a scintillation proximity assay for calcineurin phophatase activity. JBiomol Screening 1997;2:19-23.
19. De Serres M, McNulty MJ, Christensen L, Zon G, Findlay JWA: Development of a novel scintillation proximity competitive hybridization assay for the determination of phosphorothioate antisense oligonucleotide plasma concentrations in a toxicokinetic study. Anal Biochem 1996;233:228-233.
20. Sonatore LM, Wisniewski D, Frank LJ, Cameron PM, Hermes JD, Marcy Al, Salowe SP: The utility of FK506-binding protein as a fusion partner in scintillation proximity assays: application to SH2 domains. Anal Biochem 1996;240:289-297.
21. Chen T, Repetto B, Chizzonite R, Pullar C, Burghardt C, Dharm E, Zhao Z, Carroll R, Nunes P, Basu M, et al: Interaction of phosphorylated FceRly immunoglobulin receptor tyrosine activation motifbased peptides with dual and single SH2 domains of p72S)k. J Biol Chem 1996;271:25308-25315.
22. Patel S, Harris A, O'Beirne G, Cook ND, Taylor CW: Kinetic analysis of inositol triphosphate binding to pure inositol triphosphate receptors using scintillation proximity assay. Biochem Biophys Res Commun 1996;221:821-825.
23. Fox S: Heralding a new era of cell-based assays. Pharm Forum 1996;6:l-3.
24. 22.' Harris DW, Kenrick MK, Pither RJ, Anson JG, Jones DA: Development of a high volume in situ mRNA hybridization assay for the quantification of gene expression utlizing scintillating microplates. Anal Biochem 1996;243:249-256.
25. A unique application of scintillation proximity assay using scintillating microplates to quantify mRNA in situ. This method detects mRNA transcripts at the level of 10-20 copies/cell, and is 20-fold more sensitive than Northern blotting. The authors demonstrate the utility of a high throughput approach to quantify gene expression.
26. Brown MP, Royer C: Fluorescence spectroscopy as a tool to investigate protein interactions. Curr Opin Biotechnol 1997; 8:45-49.
27. 24.' Glazer AN : Recent advances in fluorescence labeling, detection and visualization. BioRadiations 1997, 94:4-8. A good review of the fundamentals of fluorescence techniques for biological measurements. Detection techniques described are easily amenable to high-throughput screening assays. A section on recent advances describes developments in fluorescence resonance energy transfer (FRET) and fluorescence in situ hybridization (FISH) technologies, membrane potential measurements, and karyotyping human chromosomes. Over 40 references are cited on various applications.
28. Czarnik AW: Desperately seeking sensors. Chem Biol 1995; 2:423428.
29. Wang GT, MatayoshiE, Huffaker JE, Kraft GA: Design and synthesis of new fluorogenic HIV protease substrates based on resonance energy transfer. Tetrahedron Lett 1991;31:6493-6496.
30. Mathis G: Probing molecular interactions with homogeneous techniques based on rare earth cryptâtes and fluorescence energy transfer. Clin Chem 1995;41:1391-1397.
31. Kolb JM, Yamanaka G, Manly SP: Use of a novel homogeneous fluorescent technology in high throughput screening. / Biomol Screening 1996, 1:203-210.
32. Gonzalez JE, Tsien RY: Voltage sensing by fluorescence resonance energy transfer. Biophys J 1995, 69:1272-1280.
33. 30: Schroeder KS, Neagle BD: FLIPR: A new instrument for accurate, high throughput optical screening. J Biomol Screening 1996; 1:7580.
34. Waggoner A, Taylor L, Seadler A, Dunlay T: Multiparameter fluorescence imaging microscopy: reagents and instruments. Hum Pathol 1996;27:494-502.
35. Jameson DM, Sawyer WH: Fluorescence anisotropy applied to biomolecular interactions. Methods Enzymol 1995;246:283-300.
36. Lundblad JR, Laurance M, Goodman RH: Fluorescence polarization analysis of protein-protein interactions. Mol Endocrinol 1996;10:607-612.
37. Checovich WJ, Böiger RE, Burke T: Fluorescence polarization-a new tool for cell and molecular biology. Nature 1995,375:254-256.
38. 35.' Levine LM, Michener ML, Toth MV, Holwerda BC: Measurement of specific protease activity utilzing fluorescence polarization. Anal Biochem 1997;247:83-88.
39. Jolley ME: Fluorescence polarization assays for the detection of proteases and their inhibitors. J Biomol Screening 1996;l:33-38.
40. Schade SZ, Jolley ME, Saurauer BJ, Simonson LG: BODIPY-aCasein, a pH-independent protein substrate for protease assays using fluorescence polarization. Anal Biochem 1996;241:l-7.
41. 38.' Lynch BA, Loiacono LA, Tiong CL, Adams SE, MacNeil IA: A fluorescence polarization based Src-SH2 binding assay. Anal Biochem 1997;247:77-82.
42. 39.' S terrer S, Henco K: Fluorescence correlation spectroscopy (PCS)A highly sensitive method to analyze drug/target interactions. J Recept Signal Transduct Res 1997; 17:511-520. This paper describes the use of fluorescence correlation spectroscopy to measure molecular interactions in a homogeneous mode. It has been developed to accommodate measurements in 96- and 384well microtiter plates, and is a good candidate for high-throughput screening applications.
43. Rigler R: Fluorescence correlations, single molecule detection and large number screening. Applications in biotechnology. J Biotechnol 1995;41:177-186.
44. Rauer B, Neumann E, Widengren J, Rigler R: Fluorescence correlation spectrometry of the interaction kinetics of tetramethylrhodamine oc-bungarotoxin with Torpedo californica acetylcholine receptor. Biophys Chem 1996;58:3-12.
45. Sarubbi E, Yanofsky SD, Barren RW, Denaro M: A cell-free, nonisotopic, high-throughput assay for inhibitors of type-1 interleukin-1 receptor. Anal Biochem 1996;237:70-75.
46. 43. Rose P, Gorman J, Kurtz S, Patel P, Fernandes P: The successful partnership of biotechnology based screen development with high throughput screening. Network Science 1996; 2(Sept):l-12. World Wide Web: www.awod.com/netsci/science/Screening/featureob/ html
47. DhundaleA.GoddardC: Receptor assays in high throughput screening laboratory: A rapid and robust first look? i Biomol Screening 1996;1:115-118.
48. Suto CM, Ignar DM: Selection of an optimal reporter gene for cell-based high throughput screening assays. J Biomol Screening 1997;2:7-9.
49. BronsteinI, Fortin J, Stanley PE, StewartGSAB, KrickaLJ: Chemiluminescent and bioluminescent reporter gene assays. Anal Biochem 1994;219:169-181.
50. Hastings WJ: Chemistries and colors of bioluminescent reactions: a review. Gen 1996;173:5-11.
51. Lehel C, Daniel-Issakani S, Brasseur M, Strulovici B: A chemiluminescent microplate assay for sensitive detection of protein kinase activity. Anal Biochem 1997;244:340-346.
52. Kolb AJ, Neumann K: Luciferase measurements in high throughput screening. J Biomol Screening 1996;l:85-88.
53. Bran MR, Messier T, Dorman C, Lannigan D: Cell-based assays for G-protein-coupled/Tyrosine kinase coupled receptors. J Biomol Screening 1996; 1:43-45.
54. Rizzuto R, Brini M, De Giorgi F, Rossi R, Heim R, Tsien RY, Pozzan T: Double labelling subcellular structures with organelletargeted GFP mutants in vivo. Curr Biol 1996; 6:183-188.
55. Janzen B, Domanico P: The 384-well plate: pros and cons. J Biomol Screening 1996;l:63-64.
56. Lutz MW, Menius A, Choi TD, Laskody RG, Domanico PL, Goetz AS, Saussy DL: Experimental design for high-throughput screening. Drug Discov Tech 1996; 1:277-286.
57. Klein RD, Geary GG: Recombinant microorganisms as tools for high throughput screening for non antibiotic compounds. J Biomol Screening 1997;2:41-49.
58. Webb SA, Hurskainen P: Transcription-specific assay for quantifying mRNA: A potential replacement for reporter gene assays. J Biomol Screening 1996; 1:119-121.
59. Charych DH, Nagy JO, Spevak W, Bednarski MD: Direct colorimetric detection of receptor-ligand interaction by a polymerized bilayer assembly. Science 1993;261:585-588.
60. 57. Charych D, Cheng Q, Reichert A, Kuziemko G, Stroh M, Nagy JO, Spevak W, Stevens RC: A 'litmus test' for molecular recognition using artificial membranes. Chem Biol 1996; 3:113-120. A unique, membrane-based colorimetric system that detects molecular interactions is described. Gangliosides that specifically bind cholera toxin, Escherichia coli enterotoxin and botulism neurotoxin were incorporated into a polydiacetylene membrane. The polymer-ized membrane containing gangliosides is blue, and turns red when the toxin is added. The response is sensitive, specific and selective. An excellent technology for high-throughput screening applications.
61. Spevak W, Foxall C, Charych DH, Dasgupta F, Nagy JO: Carbohydrates in an acidic multivalent assembly: nanomolar P-selectin inhibitors. J Med Chem 1996;38:1018-1020.
62. Allen S, Davies MC, Roberts CJ, Tendier SJB, Williams PM: Atomic force microscopy in analytical biotechnology. Trends Biotechnol 1997;15:10I-105.
63. Troy CT, Abrams SB: Scanning force microscopy helps in the design of cancer drugs. Biophoton Int 1996;Sept/Oct:52-53.
64. Paborsky LR, Dunn KE, Gibbs CS, Dougherty JP: A nickel chelate microtiter plate assay for six histidine-containing proteins. Anal Biochem 1996;234:60-65.
65. Weiss-Wiehert CH, Smetazko M, Valina-saba M, Schalkhammer TH: A new analytical device based on gated ion channels: A peptide channel biosensor. J Biomol Screening 1997; 2:11-18.
66. Brecht A, Burckardt R, Ricke J, Stemmler I, Schuetz A, Fischer S, Friedrich T, Gauglitz G, Goepel W: Transducer-based approaches for parallel binding assays in HTS. J Biomol Screening 1996; 1:191 -201.
67. TyagiS, Kramer FR: Molecular beacons: probes that fluoresce upon hybridization. Nat Biotechnol 1996; 14:303-308.
68. Heller RA, Schena M, Chai A, Shalon D, Bedilion T, Gilmore J, Woolley DE, Davis RW: Discovery and analysis of inflammatory disease-related genes using cDNA microarrays. Proc Nail Acad Sei USA 1997;94:2150-2155.
69. Nicolaou KC, Xiao XY, Parandoosh Z, Senyei A, Nova MP: Radiofrequency encoded combinatorial chemistry. Angew Chem Int £i/l 995:34:2289-2291.
70. Fitzgerald MC, Harris K, Shevlin CG, Siuzdak G: Direct characterization of solid phase resin-bound molecules by mass spectrometry. Bioorg Med Chem Lett 1996;6:979-982.
71. Chu YH, Dunnayevskiy YM, Kirby DP, Vouros P, Karger BL: Affinity capillary electrophoresis-mass spectrometry for screening combinatorial libraries. J Am Chem Soc 1996;! 18:7827-7835.
72. Evans DM, Williams KP, McGuinness B, Tarr G, Régnier F, Afeyan N, Jindal S: Affinity-based screening of combinatorial libraries using automated, serial-column chromatography. Nat Bioteclwl 1996;14:504-507.